American scientists have received information that allows them to argue that prolonged intake of aspirin helps prevent the development of skin cancer in women of the Eurasian race.
For 12 years, scientists from Stanford University School of Medicine (California) observed 60,000 white-skinned women 50-79 years old. Women reported information on their diet, medication, and occupation.
Researchers noticed that among women, for a long time and in large quantities who took aspirin, the incidence of skin cancer was the lowest. The difference compared with study participants who did not take aspirin averaged 21%. This figure reached 30% among participants who had been using aspirin for at least five years.
How does aspirin work? Dr. Gene Tan, lead author of the study, explains that this is due to the anti-inflammatory properties of aspirin. Inflammation in the body decreases - the risk of developing melanoma is reduced.
In relation to other painkillers, such a miraculous effect was not detected. But as the authors of the study themselves emphasize, until clinical studies are conducted, it is early to recommend aspirin for the prevention of skin cancer. Moreover, the drug has many contraindications: a tendency to increased bleeding, diseases of the stomach, liver, duodenum, kidneys, arterial hypertension, severe heart failure, asthma, an enlarged thyroid gland and others.
